drug
SODIUM PHENYLBUTYRATE
Marketedupdated 3mo agoby Horizon Therapeutics USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(3)
Trials studying SODIUM PHENYLBUTYRATE
- phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
- phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
- phase1An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)
Patent cliff
source: FDA Orange Bookfirst barrier falls
Sep 29, 2027
~1.1 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (29)
- Jul 27, 2040formulationUS 11583542
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036formulationUS 11154521
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036method-of-use (U-3502)US 11202767
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Oct 17, 2036formulationUS 11433041
- Dec 24, 2033method-of-use (U-3460)US 10251896
- Dec 24, 2033method-of-use (U-3460)US 10857162
- Dec 24, 2033formulationUS 11071742
- Dec 24, 2033method-of-use (U-3460)US 9872865
FDA exclusivities (2)
- Sep 29, 2029ODE-411Orphan Drug (7y)3.1y
- Sep 29, 2027NCENew Chemical Entity (5y)1.1y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 10m ago
Found something off?
comments(0)
5-min edit window · permanent after that